Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis.
about
Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of gliomaBRCA1 regulation on β-hCG: a mechanism for tumorigenicity in BRCA1 defective breast cancer.Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.Transcriptome profiling identified differentially expressed genes and pathways associated with tamoxifen resistance in human breast cancer.The impact of phosphatases on proliferative and survival signaling in cancer.
P2860
Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis.
@ast
Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis.
@en
type
label
Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis.
@ast
Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis.
@en
prefLabel
Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis.
@ast
Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis.
@en
P2093
P2860
P1433
P1476
Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis.
@en
P2093
Alexey V Sorokin
Binoj C Nair
Junjie Chen
Kathryn E Aziz
Mien-Chie Hung
Valentina Evdokimova
Yongkun Wei
P2860
P304
P356
10.1158/0008-5472.CAN-14-2718
P407
P577
2015-04-15T00:00:00Z